Evidence map›Paper›PMID 38275468›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Self-Diagnosis of SARS-CoV-2 from Saliva Samples at Home: Isothermal Amplification Enabled by Do-It-Yourself Portable Incubators and Laminated Poly-ethyl Sulfonate Membranes.

Sergio Bravo-González, Everardo González-González, Valeria Perales-Salinas, Iram Pablo Rodríguez-Sánchez, Jose E Ortiz-Castillo, Adriana Vargas-Martínez, Victor H Perez-Gonzalez, Claudia Maribel Luna-Aguirre, Grissel Trujillo-de Santiago, Mario Moisés Alvarez

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sergio Bravo-GonzálezCentro de Biotecnología-FEMSA, Tecnologico de Monterrey, Monterrey 64849, NL, Mexico.ORCID 0000-0001-6929-0040
Everardo González-GonzálezCentro de Biotecnología-FEMSA, Tecnologico de Monterrey, Monterrey 64849, NL, Mexico.
Valeria Perales-SalinasCentro de Biotecnología-FEMSA, Tecnologico de Monterrey, Monterrey 64849, NL, Mexico.ORCID 0000-0002-5811-3767
Iram Pablo Rodríguez-SánchezLaboratorio de Fisiología Molecular y Estructural, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, NL, Mexico.ORCID 0000-0002-5988-4168
Jose E Ortiz-CastilloDepartamento de Ingeniería Mecátrónica y Eléctrica, Tecnologico de Monterrey, Monterrey 64849, NL, Mexico.
Adriana Vargas-MartínezDepartamento de Ingeniería Mecátrónica y Eléctrica, Tecnologico de Monterrey, Monterrey 64849, NL, Mexico.ORCID 0000-0001-6969-6294
Victor H Perez-GonzalezDepartamento de Ingeniería Mecátrónica y Eléctrica, Tecnologico de Monterrey, Monterrey 64849, NL, Mexico.ORCID 0000-0003-4503-7774
Claudia Maribel Luna-AguirreCentro de Biotecnología-FEMSA, Tecnologico de Monterrey, Monterrey 64849, NL, Mexico.ORCID 0000-0001-9867-3585
Grissel Trujillo-de SantiagoCentro de Biotecnología-FEMSA, Tecnologico de Monterrey, Monterrey 64849, NL, Mexico.ORCID 0000-0001-9230-4607
Mario Moisés AlvarezCentro de Biotecnología-FEMSA, Tecnologico de Monterrey, Monterrey 64849, NL, Mexico.
Tecnológico de Monterrey · MXUniversidad Autónoma de Nuevo León · MX

Funding

P-Body and miRNA-Mediated Regulation of NeuroplasticityR01DA026048 · NIDA · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI BARBEE, SCOTT A · 2008 to 2011
$1.2M
Baur Endowment Chair 0020240I03Cedillo Family 2021Consejo Nacional de Humanidades, Ciencias y Tecnologías (Scholarships SNI CVU 26048; SNI CVU 256730; and Doctoral scholarships for Sergio Bravo-González and Everardo González-González)Fundación FEMSA Grant 2020, 2021, 2022
6 · The paper itself

Abstract

COVID-19 made explicit the need for rethinking the way in which we conduct testing for epidemic emergencies. During the COVID-19 pandemic, the dependence on centralized lab facilities and resource-intensive methodologies (e.g., RT-qPCR methods) greatly limited the deployment of widespread testing efforts in many developed and underdeveloped countries. Here, we illustrate the development of a simple and portable diagnostic kit that enables self-diagnosis of COVID-19 at home from saliva samples. We describe the development of a do-it-yourself (DIY) incubator for Eppendorf tubes that can be used to conduct SARS-CoV-2 detection with competitive sensitivity and selectivity from saliva at home. In a proof-of-concept experiment, we assembled Eppendorf-tube incubators at our home shop, prepared a single-tube mix of reagents and LAMP primers in our lab, and deployed these COVID-19 detection kits using urban delivery systems (i.e., Rappifavor or Uber) to more than 15 different locations in Monterrey, México. This straightforward strategy enabled rapid and cost-effective at-home molecular diagnostics of SARS-CoV-2 from real saliva samples with a high sensitivity (100%) and high selectivity (87%).

Indexed as

at homeCOVID-19diagnosticextraction freeisothermal nucleic acid amplificationLAMPportablesalivaSARS-CoV-2

Identifiers

PMID38275468
PMCPMC10814948
OpenAlexW4391035217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.